Premium
Letter: overcoming secondary loss of response to infliximab—it is not the drug, it is how you use it!
Author(s) -
Langenberg Daniel R.,
Vasudevan Abhinav
Publication year - 2018
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.14959
Subject(s) - medicine , infliximab , drug , pharmacology , tumor necrosis factor alpha